Gene therapy has emerged as a promising approach for addressing cardiovascular diseases such as hypertension, atherosclerosis and Familial Hypercholesterolemia (FH). This review explores the evolution of gene therapy techniques and their applications in the management of these cardiovascular conditions. We discuss the underlying molecular mechanisms, delivery methods and therapeutic targets utilized in gene therapy interventions for hypertension, atherosclerosis and FH. Furthermore, we highlight recent advancements, challenges and future directions in the field of cardiovascular gene therapy, with the potential to revolutionize the treatment of these prevalent and debilitating conditions.
HTML PDFShare this article
Journal of Hypertension: Open Access received 614 citations as per Google Scholar report
